youtube_live
Q2 2027 earnings • released • EPS beat +11.98% • Revenue beat +24.63%
See resultschevron_right
NATCOPHARM:NSE
Natco Pharma Ltd
₹819.55
arrow_downward
-0.41%(-3.35) 1D
Nov 18, 3:27:24 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NATCOPHARM...
Open
₹823.80
High
₹832.85
Low
₹818.10
Mkt. cap
146.80B
Avg. vol.
696.01K
Volume
1.11M
Dividend
0.52%
Quarterly dividend
₹1.06
Ex-dividend date
Oct 1, 2026
P/E ratio
17.87
52-wk high
₹1,216.89
52-wk low
₹773.60
EPS
₹45.88
Shares outstanding
182.26M
No. of employees
4K
Open
₹823.80
High
₹832.85
Low
₹818.10
Mkt. cap
146.80B
Avg. vol.
696.01K
Volume
1.11M
Dividend
0.52%
Quarterly dividend
₹1.06
Ex-dividend date
Oct 1, 2026
P/E ratio
17.87
52-wk high
₹1,216.89
52-wk low
₹773.60
EPS
₹45.88
Shares outstanding
182.26M
No. of employees
4K
News stories
From web sources and news partners
NDTV Profit
·
2 days ago
Natco Pharma Shares Rally 9% Despite Weak Q2 Results; Details Inside
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4.43K
Founded1981
HeadquartersBanjara Hills, Telangana, India
SectorHealth Care
IndustryPharmaceutical industry
Websitenatcopharma.co.in